Stock Analysis of Aadi Bioscience Inc (AADI) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code AADI
Close 1.91
Change -0.0050 / 0.261 %
Volume 92205.00
Vol Change 20254.00 / 28.15 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Very Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Aadi Bioscience Inc
PE (TTM)

-187.01

Very Poor
Price / Book

108.86

Very Poor
Price / Sales

539.94

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

46898.52 K

Enterprise Value

-15555.48 K

ROA (TTM)

-48.81

Very Poor
ROE (TTM)

-58.21

Very Poor
Net Margin (TTM)

-288.72

Very Poor
Revenue

52.83 %

23255.00 K
Net Profit

4.79 %

-63409.00 K
Debt to Equity

0.0041

Excellent
Altman Z Score

-2.32

Very Poor
Quick Ratio

4.48

Very Good
Cash Ratio

4.12

Very Good


Highs/Lows of Aadi Bioscience Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.78 7.30 % 1.54 % 1.981.8113-May-2414-May-24
Two Week2.12 9.91 % 3.42 % 2.131.707-May-2408-May-24
One Month1.82 4.95 % 5.60 % 2.131.6607-May-2426-Apr-24
Three Month1.9 0.526 % 5.95 % 2.471.6604-Mar-2426-Apr-24
Six Months4.71 59.45 % 17.48 % 5.71.5529-Nov-2317-Jan-24
One year7.295 73.82 % 27.52 % 8.61.5523-May-2317-Jan-24
Two year15.05 87.31 % 29.70 % 14.7721.5503-Oct-2217-Jan-24
Five year15.15 87.39 % 85.46 % 14.7721.5503-Oct-2217-Jan-24


Technical View of Aadi Bioscience Inc
RSI

49.11

Neutral
MACD

-0.0261

Whipsaw
ADX

16.87

Neutral
Super Trend

1.71

Mild Bullish
Williams %R

-51.16

Neutral
CCI

17.40

Neutral


EMA 5

1.89

Strong Bullish
EMA 15

1.90

Mild Bullish
EMA 50

1.99

Mild Bearish
EMA 100

2.37

Mild Bearish
SMA 100

1.94

Whipsaw
SMA 200

3.43

Mild Bearish
SMA 5 / 20

1.88 / 1.89

Strong Bearish
SMA 15 / 50

1.93 / 2.01

Mild Bearish
SMA 50 / 200

2.01 / 3.43

Mild Bearish




Charts of Aadi Bioscience Inc


Returns of Aadi Bioscience Inc with Peers
Period / StockAADILUCDLNSRNXTC
1 Week7.30%-4.17%8.99%1.21%
1 Mth4.95%12.83%34.64%10.60%
3 Mth0.526%-33.46%-11.21%14.38%
6mth-59.45%-30.92%88.13%30.47%
1 Year-73.82%-40.07%73.84%-4.57%
2 Year-87.31%-59.05%-42.22%-55.82%
5 Years-87.39%---91.57%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Aadi Bioscience Inc with Peers
Ratio / StockAADILUCDLNSRNXTC
PE-187.01-0.0015-3.85-0.748
P/B108.860.00451.020.327
ROA-48.81-102.51-18.32-39.49
ROE-58.21-301.00-34.76-43.71
Debt To Equity0.0041-6.510.01670.0057
Revenue23255.00 K
52.83 % 		1500.00 K
297.88 % 		42164.00 K
19.25 % 		0
%
Net Income-63409.00 K
4.79 % 		-56764.00 K
1.06 % 		-14383.00 K
27.77 % 		-65556.00 K
12.28 %


Technicals of Aadi Bioscience Inc with Peers
Technical / StockAADILUCDLNSRNXTC-
ADX16.8727.5028.9415.32
CMF-0.0175-0.0281-0.078-0.248
MFI42.2369.5973.7360.20
RSI49.1149.5567.9153.13
MACD Abv SignalTrueTrueTrueTrue
Price Above 50 MAFalseFalseTrueFalse-
Price Above 200 MAFalseFalseTrueTrue-


About : Aadi Bioscience Inc

Address : 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272
Tel : 424-744-8055
URL : https://aadibio.com
Code : AADI, ISIN : US00032Q1040, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 08_Aug_2017
Employee Count : 75

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)